Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Exothera has acquired the NevoLine Upstream manufacturing platform, the latest equipment of Univercells Technologies.
read more
PromoCell has successfully completed a comprehensive EXCiPACT audit that certifies the company as a manufacturer of pharmaceutical excipients to GMP standards.
read more
Wednesday, January 27, 2021
Ajinomoto Bio-Pharma Services and Humanigen will be expanding their manufacturing agreement for the fill finish supply of lenzilumab.
read more
Wednesday, January 27, 2021
Adare Pharma Solutions has announced the opening of a new small-scale development laboratory in Vandalia, Ohio.
read more
Tuesday, January 26, 2021
The FDA has issued a guidance to notify drug manufacturers, including repackers, relabelers, alcohol suppliers and compounders, of FDA’s policy on testing of alcohol or isopropyl alcohol for methanol prior to using the ingredient in drugs.
read more
Tuesday, January 26, 2021
Aphena Pharma has announced the continuing $21 million expansion of its Solid Dose Division in Cookeville, Tennessee.
read more
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Wednesday, January 20, 2021
Gritstone has obtained a nonexclusive license to Genevant’s LNP technology to develop and commercialize SAM vaccines against SARS-CoV-2.
read more
Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate.
read more
Wednesday, January 13, 2021
Catalent has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics.
read more
Wednesday, January 13, 2021
RheinCell Therapeutics GmbH has received GMP certification and Manufacturing Authorization.
read more
Tuesday, January 12, 2021
Alcami announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC.
read more